Clinically Actionable Strategies for Studying Neural Influences in Cancer

Ihsan Ekin Demir1, Carmen Mota Reyes2, Wasfi Alrawashdeh3

  • 1Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.

Cancer Cell
|June 13, 2020
PubMed

Insights

Cancer growth involves neuro-glial activation. Targeting tumor hyperinnervation shows promise, necessitating systematic analysis of neural influences in cancer (NIC) and strategies for clinical translation.

Area of Science:

  • Oncology
  • Neuroscience
  • Cancer Biology

Background:

  • Neuro-glial activation is an emerging hallmark of cancer.
  • Tumor hyperinnervation is increasingly recognized as a key factor in cancer progression.
  • Preclinical and early clinical studies suggest targeting neural influences in cancer (NIC) can yield antitumor effects.

Purpose of the Study:

  • To outline strategies for translating findings on neural influences in cancer from preclinical research to clinical application.
  • To emphasize the importance of systematic analysis of NIC in cancer therapy development.

Main Methods:

  • Review and synthesis of current research on neuro-glial activation and tumor hyperinnervation.
  • Analysis of preclinical data and early clinical trial results.
  • Development of a framework for clinical translation of NIC-targeting strategies.

Main Results:

  • Identification of neuro-glial activation as a significant factor in cancer.
  • Demonstration of promising antitumor effects from targeting tumor hyperinnervation.
  • Highlighting the need for systematic approaches to study NIC.

Conclusions:

  • Translating the targeting of neural influences in cancer from bench to bedside requires strategic planning.
  • Systematic analysis of NIC is crucial for developing novel cancer therapies.
  • Further research and clinical trials are warranted to fully exploit the therapeutic potential of targeting neural pathways in cancer.